1. Home
  2. WHG vs ARCT Comparison

WHG vs ARCT Comparison

Compare WHG & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Westwood Holdings Group Inc

WHG

Westwood Holdings Group Inc

HOLD

Current Price

$18.96

Market Cap

185.2M

Sector

Finance

ML Signal

HOLD

Logo Arcturus Therapeutics Holdings Inc.

ARCT

Arcturus Therapeutics Holdings Inc.

HOLD

Current Price

$13.33

Market Cap

163.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WHG
ARCT
Founded
1983
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
185.2M
163.4M
IPO Year
2002
2019

Fundamental Metrics

Financial Performance
Metric
WHG
ARCT
Price
$18.96
$13.33
Analyst Decision
Strong Buy
Analyst Count
0
13
Target Price
N/A
★ $23.20
AVG Volume (30 Days)
11.2K
★ 787.3K
Earning Date
10-29-2026
11-09-2026
Dividend Yield
★ 3.15%
N/A
EPS Growth
★ 203.85
20.00
EPS
★ 0.25
N/A
Revenue
★ $97,762,000.00
$82,031,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$58.72
P/E Ratio
$76.12
★ N/A
Revenue Growth
★ 3.21
N/A
52 Week Low
$14.70
$5.50
52 Week High
$20.97
$24.14

Technical Indicators

Market Signals
Indicator
WHG
ARCT
Relative Strength Index (RSI) 49.72 48.02
Support Level $18.87 $13.12
Resistance Level $20.26 $17.85
Average True Range (ATR) 0.44 1.37
MACD 0.05 -0.36
Stochastic Oscillator 48.45 14.20

Price Performance

Historical Comparison
WHG
ARCT

About WHG Westwood Holdings Group Inc

Westwood Holdings Group Inc manages investment assets and provides services for clients through subsidiaries. It operates its business through the Advisory and Trust segments. Its Advisory segment provides investment advisory services to corporate retirement plans, public retirement plans, endowments, foundations, individuals and the Westwood Funds, as well as investment sub-advisory services to mutual funds and its trust segment. The Trust segment offers trust and custodial services to its clients and its advisory segment sponsors common trust funds to institutions and high net-worth individuals. It generates maximum revenue from the Advisory segment. Geographically, it derives a majority of its revenue from the United States, and also has its presence in Canada.

About ARCT Arcturus Therapeutics Holdings Inc.

Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. It operates in one business segment, which includes all activities related to the discovery, development, and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC and LUNAR-CF. Its Vaccine candidates include LUNAR-FLU, KOSTAIVE XBB.1.5, KOSTAIVE, and Others.

Share on Social Networks: